Literature DB >> 33235416

Comparison of Minimally Invasive Thrombectomy with Percutaneous Balloon Angioplasty for Organized Thrombi in Hemodialysis Access.

Jun-Ted Chong1, Ping-Yen Liu2, Mu-Shiang Huang2, Wei-Da Lu2.   

Abstract

BACKGROUND: Thrombi are an important challenge when establishing hemodialysis access for hemodialysis. We developed a minimally invasive thrombectomy (MIT) salvage treatment to solve this problem when traditional percutaneous transluminal angioplasty (PTA) fails.
OBJECTIVES: The study aimed to investigate the safety and patency rate following MIT as a rescue procedure for traditional PTA with organized thrombi obstructing hemodialysis access.
METHODS: This was a prospective study of MIT as a rescue procedure for traditional PTA to remove organized thrombi and establish hemodialysis access. We included patients with (1) stenotic lesions, (2) vascular access thrombi, (3) high venous pressure, (4) vascular collapse and suction. Nephrologists evaluated hemodialysis access immediately post-thrombi removal and patency at 7, 30, 60, 120, and 180 days post-removal, in addition to complications. Kaplan-Meier survival analysis was performed to analyze the primary and secondary patency rates after clinical procedural success.
RESULTS: From June 2014 to May 2015, 746 patients underwent PTA in our hospital, and 425 patients consented to participate in this study. Of these patients, we enrolled 46 who underwent simultaneous PTA and MIT. Immediate clinical success was achieved in 100% of the patients in the MIT group. No complications were observed in any of the 46 patients, including major bleeding, shock, or hospitalization. The primary and secondary patency rates did not differ between MIT and PTA alone (p = 0.93 and p = 0.28, respectively).
CONCLUSIONS: MIT can be considered a safe rescue procedure for removing organized thrombi to establish vascular access for hemodialysis when initial and traditional PTA fails.

Entities:  

Keywords:  Angioplasty; Hemodialysis; Organized thrombi; Thrombectomy

Year:  2020        PMID: 33235416      PMCID: PMC7677639          DOI: 10.6515/ACS.202011_36(6).20200621B

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  11 in total

Review 1.  Reporting standards for clinical evaluation of new peripheral arterial revascularization devices.

Authors:  David Sacks; David L Marinelli; Louis G Martin; James B Spies
Journal:  J Vasc Interv Radiol       Date:  2003-09       Impact factor: 3.464

2.  Pharmacomechanical thrombectomy with the Castañeda brush catheter in thrombosed hemodialysis grafts and native fistulas.

Authors:  Sam Heye; Filip Van Kerkhove; Kathleen Claes; Geert Maleux
Journal:  J Vasc Interv Radiol       Date:  2007-11       Impact factor: 3.464

3.  Treatment of thrombosed hemodialysis access grafts: Arrow-Trerotola percutaneous thrombolytic device versus pulse-spray thrombolysis. Arrow-Trerotola Percutaneous Thrombolytic Device Clinical Trial.

Authors:  S O Trerotola; T M Vesely; G B Lund; M C Soulen; K O Ehrman; J F Cardella
Journal:  Radiology       Date:  1998-02       Impact factor: 11.105

4.  A metaanalysis comparing surgical thrombectomy, mechanical thrombectomy, and pharmacomechanical thrombolysis for thrombosed dialysis grafts.

Authors:  Lawrence D Green; Douglas S Lee; Daryl S Kucey
Journal:  J Vasc Surg       Date:  2002-11       Impact factor: 4.268

5.  Comparison of the angiojet rheolytic catheter to surgical thrombectomy for the treatment of thrombosed hemodialysis grafts. Peripheral AngioJet Clinical Trial.

Authors:  T M Vesely; D Williams; M Weiss; M Hicks; B Stainken; T Matalon; B Dolmatch
Journal:  J Vasc Interv Radiol       Date:  1999-10       Impact factor: 3.464

Review 6.  Catheter interventions for hemodialysis fistulas and grafts.

Authors:  John A Bittl
Journal:  JACC Cardiovasc Interv       Date:  2010-01       Impact factor: 11.195

7.  Thrombosed arteriovenous fistula for hemodialysis access is characterized by a marked inflammatory activity.

Authors:  Chi-Jen Chang; Yu-Shien Ko; Po-Jen Ko; Lung-An Hsu; Chin-Fen Chen; Chih-Wei Yang; Tsu-Shiu Hsu; Jong-Hwei S Pang
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

Review 8.  Safety and efficacy of the AngioJet device in the treatment of thrombosed arteriovenous fistula and grafts: A systematic review.

Authors:  Philip Gc Chan; Gerard S Goh
Journal:  J Vasc Access       Date:  2018-03-16       Impact factor: 2.283

9.  Increased platelet deposition on polytetrafluoroethylene grafts after balloon catheter thrombectomy.

Authors:  F R Bech; S W Galt; J L Cronenwett
Journal:  J Vasc Surg       Date:  1990-06       Impact factor: 4.268

10.  Endovascular Declotting of Wall-Adherent Thrombi in Hemodialysis Vascular Access.

Authors:  Chih-Wei Hung; Chao-Lun Lai; Mu-Yang Hsieh; Ruei-Cheng Kuo; Kuei-Chin Tsai; Lin Lin; Chih-Cheng Wu
Journal:  Acta Cardiol Sin       Date:  2014-03       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.